United States Precision Medicine Market is expected to hit US$ 62.80 billion by 2033 | Major Companies - F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., AstraZeneca, Pfizer Inc., GSK plc

Market Size and Growth:

The Precision Medicine Market size reached US$ 98.87 billion in 2024 and is expected to reach US$ 329.73 billion by 2033, growing at a CAGR of 14.8% during the forecast period of 2025-2033.

DataM Intelligence has published a new research report on "Precision Medicine Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/precision-medicine-market?sz

The Precision Medicine Market refers to the global industry focused on developing and delivering personalized healthcare solutions tailored to an individual's genetic profile, lifestyle, and environmental factors. It integrates advanced technologies such as genomics, molecular diagnostics, bioinformatics, and targeted therapeutics to improve treatment accuracy and outcomes. By leveraging data-driven insights, precision medicine enables customized disease prevention, diagnosis, and therapy, particularly in oncology, rare diseases, and chronic conditions, reducing adverse effects while enhancing clinical effectiveness and healthcare efficiency.

Recent Key Developments of United States:

✅ January 2026: The FDA granted critical designations to novel therapies like RAS inhibitors and cell therapies for rare blood cancers, emphasizing precision medicine in oncology. Anticipated approvals included Enhertu with pertuzumab for HER2-positive breast cancer and TAR-200 for high-risk non-muscle invasive bladder cancer, advancing targeted treatments.

✅ December 2025: A baby boy with a rare metabolic disorder received the first bespoke gene-editing therapy, enabling him to take his first steps, highlighting advances in individualized genetic interventions. The FDA demonstrated willingness to use real-world data (RWD) for regulatory evidence in rare diseases and n-of-1 trials during its June roundtable, with ongoing impacts into late 2025.

✅ November 2025: The FDA announced a new Plausible Mechanism (PM) Pathway to support additional "N-of-1" therapies for ultra-rare genetic diseases, accelerating access to personalized treatments. This followed the 2025 approval of etuvetidigene autotemcel (WASKYRA) for Wiskott-Aldrich syndrome, marking a historic non-profit led approval.

Recent Key Developments of Japan:

✅ January 2026: Inocras partnered with Summit Pharmaceuticals to expand clinical whole-genome sequencing labs and bioinformatics for precision diagnostics. Takara Bio acquired a genomic analysis firm to advance sequencing and spatial biology in clinical genomics.

✅ December 2025: Thermo Fisher Scientific acquired a regional genomics reagent and diagnostics distributor to boost advanced sequencing adoption. Daiichi Sankyo expanded oncology genomic programs with next-generation sequencing for personalized cancer therapies.

✅ November 2025: QIAGEN acquired a Japanese bioinformatics software provider to enhance clinical genomics data interpretation for hospitals adopting precision medicine. JFCR and NEC confirmed research results on personalized neoantigen cancer vaccines using whole-genome data and AI, predicting cryptic antigens in breast cancer and soft tissue sarcoma.

List of the Key Players in the Precision Medicine Market:

F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
AstraZeneca
Pfizer Inc.
GSK plc
Biogen
Bristol-Myers Squibb Company
Abbott
Merck & Co., Inc.
BGI

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/precision-medicine-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Precision Medicine Market:

By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Others.

By Application: Diagnostics, Therapeutics, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=precision-medicine-market

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Precision Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Precision Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Precision Medicine Market in 2026?
◆ What is the projected growth rate of the Precision Medicine Market through 2034?
◆ Who are the key players in the Precision Medicine Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.